β-Adrenergic blockade attenuates adverse adipose tissue responses after burn

Severe burn injuries are defined by a prolonged hypermetabolic response characterized by increases in resting energy expenditure, systemic catabolism, and multi-organ dysfunction. The sustained elevation of catecholamines following a burn injury is thought to significantly contribute to this hyperme...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of molecular medicine (Berlin, Germany) Germany), 2024-10, Vol.102 (10), p.1245-1254
Hauptverfasser: Bieerkehazhi, Shayahati, Abdullahi, Abdikarim, Khalaf, Fadi, Barayan, Dalia, de Brito Monteiro, Lauar, Samadi, Osai, Rix, Graham, Jeschke, Marc G.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1254
container_issue 10
container_start_page 1245
container_title Journal of molecular medicine (Berlin, Germany)
container_volume 102
creator Bieerkehazhi, Shayahati
Abdullahi, Abdikarim
Khalaf, Fadi
Barayan, Dalia
de Brito Monteiro, Lauar
Samadi, Osai
Rix, Graham
Jeschke, Marc G.
description Severe burn injuries are defined by a prolonged hypermetabolic response characterized by increases in resting energy expenditure, systemic catabolism, and multi-organ dysfunction. The sustained elevation of catecholamines following a burn injury is thought to significantly contribute to this hypermetabolic response, leading to changes in adipose tissue such as increased lipolysis and the browning of subcutaneous white adipose tissue (WAT). Failure to mitigate these adverse changes within the adipose tissue has been shown to exacerbate the post-burn hypermetabolic response and lead to negative outcomes. Propranolol, a non-selective β-blocker, has been clinically administered to improve outcomes of pediatric and adult burn patients, but there is inadequate knowledge of its effects on the distinct adipose tissue depots. In this study, we investigated the adipose depot-specific alterations that occur in response to burn injury. Moreover, we explored the therapeutic effects of β-adrenoceptor blockade via the drug propranolol in attenuating these burn-induced pathophysiological changes within the different fat depots. Using a murine model of thermal injury, we show that burn injury induces endoplasmic reticulum (ER) stress in the epididymal (eWAT) but not in the inguinal (iWAT) WAT depot. Conversely, burn injury induces the activation of key lipolytic pathways in both eWAT and iWAT depots. Treatment of burn mice with propranolol effectively mitigated adverse burn-induced alterations in the adipose by alleviating ER stress in the eWAT and reducing lipolysis in both depots. Furthermore, propranolol treatment in post-burn mice attenuated UCP1-mediated subcutaneous WAT browning following injury. Overall, our findings suggest that propranolol serves as an effective therapeutic intervention to mitigate the adverse changes induced by burn injury, including ER stress, lipotoxicity, and WAT browning, in both adipose tissue depots. Key messages Burn injury adversely affects adipose tissue metabolism via distinct changes in both visceral and subcutaneous adipose depots. Propranolol, a non-selective β-adrenergic blocker, attenuates many of the adverse adipose tissue changes mediated by burn injury.
doi_str_mv 10.1007/s00109-024-02478-w
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3093175795</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3093175795</sourcerecordid><originalsourceid>FETCH-LOGICAL-c256t-589db547ee2296283554f226a32e2c6487c43b4d2904250ace2ea6f739e29513</originalsourceid><addsrcrecordid>eNp9kE1OwzAQRi0EoqVwARYoEhs2AXtsx_GyqviTith0bznJpEpJk2InIK7FQTgTLikgsWBhjWS_-Wb8CDll9JJRqq48pYzqmILYHpXGr3tkzASHmAlB98mYapHEoFgyIkferwKupBaHZMQ1EzJlYkwePt7jaeGwQbes8iir2_zJFhjZrsOmtx36yBYv6Hy4KqpNG2pXed9j5NBv2sZvgbJDF2W9a47JQWlrjye7OiGLm-vF7C6eP97ez6bzOAeZdLFMdZFJoRABdAIpl1KUAInlgJAnIlW54JkoQFMBktocAW1SKq4RtGR8Qi6G2I1rn3v0nVlXPse6tg22vTecah6-qrQM6PkfdNWGRcNyhjOqJLAUeKBgoHLXeu-wNBtXra17M4yarWszuDbBs_lybV5D09kuus_WWPy0fMsNAB8AH56aJbrf2f_EfgLyOInJ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3107521823</pqid></control><display><type>article</type><title>β-Adrenergic blockade attenuates adverse adipose tissue responses after burn</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Bieerkehazhi, Shayahati ; Abdullahi, Abdikarim ; Khalaf, Fadi ; Barayan, Dalia ; de Brito Monteiro, Lauar ; Samadi, Osai ; Rix, Graham ; Jeschke, Marc G.</creator><creatorcontrib>Bieerkehazhi, Shayahati ; Abdullahi, Abdikarim ; Khalaf, Fadi ; Barayan, Dalia ; de Brito Monteiro, Lauar ; Samadi, Osai ; Rix, Graham ; Jeschke, Marc G.</creatorcontrib><description>Severe burn injuries are defined by a prolonged hypermetabolic response characterized by increases in resting energy expenditure, systemic catabolism, and multi-organ dysfunction. The sustained elevation of catecholamines following a burn injury is thought to significantly contribute to this hypermetabolic response, leading to changes in adipose tissue such as increased lipolysis and the browning of subcutaneous white adipose tissue (WAT). Failure to mitigate these adverse changes within the adipose tissue has been shown to exacerbate the post-burn hypermetabolic response and lead to negative outcomes. Propranolol, a non-selective β-blocker, has been clinically administered to improve outcomes of pediatric and adult burn patients, but there is inadequate knowledge of its effects on the distinct adipose tissue depots. In this study, we investigated the adipose depot-specific alterations that occur in response to burn injury. Moreover, we explored the therapeutic effects of β-adrenoceptor blockade via the drug propranolol in attenuating these burn-induced pathophysiological changes within the different fat depots. Using a murine model of thermal injury, we show that burn injury induces endoplasmic reticulum (ER) stress in the epididymal (eWAT) but not in the inguinal (iWAT) WAT depot. Conversely, burn injury induces the activation of key lipolytic pathways in both eWAT and iWAT depots. Treatment of burn mice with propranolol effectively mitigated adverse burn-induced alterations in the adipose by alleviating ER stress in the eWAT and reducing lipolysis in both depots. Furthermore, propranolol treatment in post-burn mice attenuated UCP1-mediated subcutaneous WAT browning following injury. Overall, our findings suggest that propranolol serves as an effective therapeutic intervention to mitigate the adverse changes induced by burn injury, including ER stress, lipotoxicity, and WAT browning, in both adipose tissue depots. Key messages Burn injury adversely affects adipose tissue metabolism via distinct changes in both visceral and subcutaneous adipose depots. Propranolol, a non-selective β-adrenergic blocker, attenuates many of the adverse adipose tissue changes mediated by burn injury.</description><identifier>ISSN: 0946-2716</identifier><identifier>ISSN: 1432-1440</identifier><identifier>EISSN: 1432-1440</identifier><identifier>DOI: 10.1007/s00109-024-02478-w</identifier><identifier>PMID: 39145814</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Adipose tissue ; Adipose Tissue - drug effects ; Adipose Tissue - metabolism ; Adipose Tissue, White - drug effects ; Adipose Tissue, White - metabolism ; Adrenergic beta-Antagonists - pharmacology ; Adrenergic beta-Antagonists - therapeutic use ; Adrenergic receptors ; Animal models ; Animals ; Biomedical and Life Sciences ; Biomedicine ; Body fat ; Burn patients ; Burns ; Burns - drug therapy ; Burns - metabolism ; Catecholamines ; Disease Models, Animal ; Endoplasmic reticulum ; Endoplasmic Reticulum Stress - drug effects ; Energy expenditure ; Energy Metabolism - drug effects ; Human Genetics ; Internal Medicine ; Lipolysis ; Lipolysis - drug effects ; Male ; Mice ; Mice, Inbred C57BL ; Molecular Medicine ; Original Article ; Pediatrics ; Propranolol ; Propranolol - pharmacology ; Propranolol - therapeutic use ; Thermal injury</subject><ispartof>Journal of molecular medicine (Berlin, Germany), 2024-10, Vol.102 (10), p.1245-1254</ispartof><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c256t-589db547ee2296283554f226a32e2c6487c43b4d2904250ace2ea6f739e29513</cites><orcidid>0000-0003-0870-1664</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00109-024-02478-w$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00109-024-02478-w$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39145814$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bieerkehazhi, Shayahati</creatorcontrib><creatorcontrib>Abdullahi, Abdikarim</creatorcontrib><creatorcontrib>Khalaf, Fadi</creatorcontrib><creatorcontrib>Barayan, Dalia</creatorcontrib><creatorcontrib>de Brito Monteiro, Lauar</creatorcontrib><creatorcontrib>Samadi, Osai</creatorcontrib><creatorcontrib>Rix, Graham</creatorcontrib><creatorcontrib>Jeschke, Marc G.</creatorcontrib><title>β-Adrenergic blockade attenuates adverse adipose tissue responses after burn</title><title>Journal of molecular medicine (Berlin, Germany)</title><addtitle>J Mol Med</addtitle><addtitle>J Mol Med (Berl)</addtitle><description>Severe burn injuries are defined by a prolonged hypermetabolic response characterized by increases in resting energy expenditure, systemic catabolism, and multi-organ dysfunction. The sustained elevation of catecholamines following a burn injury is thought to significantly contribute to this hypermetabolic response, leading to changes in adipose tissue such as increased lipolysis and the browning of subcutaneous white adipose tissue (WAT). Failure to mitigate these adverse changes within the adipose tissue has been shown to exacerbate the post-burn hypermetabolic response and lead to negative outcomes. Propranolol, a non-selective β-blocker, has been clinically administered to improve outcomes of pediatric and adult burn patients, but there is inadequate knowledge of its effects on the distinct adipose tissue depots. In this study, we investigated the adipose depot-specific alterations that occur in response to burn injury. Moreover, we explored the therapeutic effects of β-adrenoceptor blockade via the drug propranolol in attenuating these burn-induced pathophysiological changes within the different fat depots. Using a murine model of thermal injury, we show that burn injury induces endoplasmic reticulum (ER) stress in the epididymal (eWAT) but not in the inguinal (iWAT) WAT depot. Conversely, burn injury induces the activation of key lipolytic pathways in both eWAT and iWAT depots. Treatment of burn mice with propranolol effectively mitigated adverse burn-induced alterations in the adipose by alleviating ER stress in the eWAT and reducing lipolysis in both depots. Furthermore, propranolol treatment in post-burn mice attenuated UCP1-mediated subcutaneous WAT browning following injury. Overall, our findings suggest that propranolol serves as an effective therapeutic intervention to mitigate the adverse changes induced by burn injury, including ER stress, lipotoxicity, and WAT browning, in both adipose tissue depots. Key messages Burn injury adversely affects adipose tissue metabolism via distinct changes in both visceral and subcutaneous adipose depots. Propranolol, a non-selective β-adrenergic blocker, attenuates many of the adverse adipose tissue changes mediated by burn injury.</description><subject>Adipose tissue</subject><subject>Adipose Tissue - drug effects</subject><subject>Adipose Tissue - metabolism</subject><subject>Adipose Tissue, White - drug effects</subject><subject>Adipose Tissue, White - metabolism</subject><subject>Adrenergic beta-Antagonists - pharmacology</subject><subject>Adrenergic beta-Antagonists - therapeutic use</subject><subject>Adrenergic receptors</subject><subject>Animal models</subject><subject>Animals</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Body fat</subject><subject>Burn patients</subject><subject>Burns</subject><subject>Burns - drug therapy</subject><subject>Burns - metabolism</subject><subject>Catecholamines</subject><subject>Disease Models, Animal</subject><subject>Endoplasmic reticulum</subject><subject>Endoplasmic Reticulum Stress - drug effects</subject><subject>Energy expenditure</subject><subject>Energy Metabolism - drug effects</subject><subject>Human Genetics</subject><subject>Internal Medicine</subject><subject>Lipolysis</subject><subject>Lipolysis - drug effects</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Molecular Medicine</subject><subject>Original Article</subject><subject>Pediatrics</subject><subject>Propranolol</subject><subject>Propranolol - pharmacology</subject><subject>Propranolol - therapeutic use</subject><subject>Thermal injury</subject><issn>0946-2716</issn><issn>1432-1440</issn><issn>1432-1440</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1OwzAQRi0EoqVwARYoEhs2AXtsx_GyqviTith0bznJpEpJk2InIK7FQTgTLikgsWBhjWS_-Wb8CDll9JJRqq48pYzqmILYHpXGr3tkzASHmAlB98mYapHEoFgyIkferwKupBaHZMQ1EzJlYkwePt7jaeGwQbes8iir2_zJFhjZrsOmtx36yBYv6Hy4KqpNG2pXed9j5NBv2sZvgbJDF2W9a47JQWlrjye7OiGLm-vF7C6eP97ez6bzOAeZdLFMdZFJoRABdAIpl1KUAInlgJAnIlW54JkoQFMBktocAW1SKq4RtGR8Qi6G2I1rn3v0nVlXPse6tg22vTecah6-qrQM6PkfdNWGRcNyhjOqJLAUeKBgoHLXeu-wNBtXra17M4yarWszuDbBs_lybV5D09kuus_WWPy0fMsNAB8AH56aJbrf2f_EfgLyOInJ</recordid><startdate>20241001</startdate><enddate>20241001</enddate><creator>Bieerkehazhi, Shayahati</creator><creator>Abdullahi, Abdikarim</creator><creator>Khalaf, Fadi</creator><creator>Barayan, Dalia</creator><creator>de Brito Monteiro, Lauar</creator><creator>Samadi, Osai</creator><creator>Rix, Graham</creator><creator>Jeschke, Marc G.</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-0870-1664</orcidid></search><sort><creationdate>20241001</creationdate><title>β-Adrenergic blockade attenuates adverse adipose tissue responses after burn</title><author>Bieerkehazhi, Shayahati ; Abdullahi, Abdikarim ; Khalaf, Fadi ; Barayan, Dalia ; de Brito Monteiro, Lauar ; Samadi, Osai ; Rix, Graham ; Jeschke, Marc G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c256t-589db547ee2296283554f226a32e2c6487c43b4d2904250ace2ea6f739e29513</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adipose tissue</topic><topic>Adipose Tissue - drug effects</topic><topic>Adipose Tissue - metabolism</topic><topic>Adipose Tissue, White - drug effects</topic><topic>Adipose Tissue, White - metabolism</topic><topic>Adrenergic beta-Antagonists - pharmacology</topic><topic>Adrenergic beta-Antagonists - therapeutic use</topic><topic>Adrenergic receptors</topic><topic>Animal models</topic><topic>Animals</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Body fat</topic><topic>Burn patients</topic><topic>Burns</topic><topic>Burns - drug therapy</topic><topic>Burns - metabolism</topic><topic>Catecholamines</topic><topic>Disease Models, Animal</topic><topic>Endoplasmic reticulum</topic><topic>Endoplasmic Reticulum Stress - drug effects</topic><topic>Energy expenditure</topic><topic>Energy Metabolism - drug effects</topic><topic>Human Genetics</topic><topic>Internal Medicine</topic><topic>Lipolysis</topic><topic>Lipolysis - drug effects</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Molecular Medicine</topic><topic>Original Article</topic><topic>Pediatrics</topic><topic>Propranolol</topic><topic>Propranolol - pharmacology</topic><topic>Propranolol - therapeutic use</topic><topic>Thermal injury</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bieerkehazhi, Shayahati</creatorcontrib><creatorcontrib>Abdullahi, Abdikarim</creatorcontrib><creatorcontrib>Khalaf, Fadi</creatorcontrib><creatorcontrib>Barayan, Dalia</creatorcontrib><creatorcontrib>de Brito Monteiro, Lauar</creatorcontrib><creatorcontrib>Samadi, Osai</creatorcontrib><creatorcontrib>Rix, Graham</creatorcontrib><creatorcontrib>Jeschke, Marc G.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of molecular medicine (Berlin, Germany)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bieerkehazhi, Shayahati</au><au>Abdullahi, Abdikarim</au><au>Khalaf, Fadi</au><au>Barayan, Dalia</au><au>de Brito Monteiro, Lauar</au><au>Samadi, Osai</au><au>Rix, Graham</au><au>Jeschke, Marc G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>β-Adrenergic blockade attenuates adverse adipose tissue responses after burn</atitle><jtitle>Journal of molecular medicine (Berlin, Germany)</jtitle><stitle>J Mol Med</stitle><addtitle>J Mol Med (Berl)</addtitle><date>2024-10-01</date><risdate>2024</risdate><volume>102</volume><issue>10</issue><spage>1245</spage><epage>1254</epage><pages>1245-1254</pages><issn>0946-2716</issn><issn>1432-1440</issn><eissn>1432-1440</eissn><abstract>Severe burn injuries are defined by a prolonged hypermetabolic response characterized by increases in resting energy expenditure, systemic catabolism, and multi-organ dysfunction. The sustained elevation of catecholamines following a burn injury is thought to significantly contribute to this hypermetabolic response, leading to changes in adipose tissue such as increased lipolysis and the browning of subcutaneous white adipose tissue (WAT). Failure to mitigate these adverse changes within the adipose tissue has been shown to exacerbate the post-burn hypermetabolic response and lead to negative outcomes. Propranolol, a non-selective β-blocker, has been clinically administered to improve outcomes of pediatric and adult burn patients, but there is inadequate knowledge of its effects on the distinct adipose tissue depots. In this study, we investigated the adipose depot-specific alterations that occur in response to burn injury. Moreover, we explored the therapeutic effects of β-adrenoceptor blockade via the drug propranolol in attenuating these burn-induced pathophysiological changes within the different fat depots. Using a murine model of thermal injury, we show that burn injury induces endoplasmic reticulum (ER) stress in the epididymal (eWAT) but not in the inguinal (iWAT) WAT depot. Conversely, burn injury induces the activation of key lipolytic pathways in both eWAT and iWAT depots. Treatment of burn mice with propranolol effectively mitigated adverse burn-induced alterations in the adipose by alleviating ER stress in the eWAT and reducing lipolysis in both depots. Furthermore, propranolol treatment in post-burn mice attenuated UCP1-mediated subcutaneous WAT browning following injury. Overall, our findings suggest that propranolol serves as an effective therapeutic intervention to mitigate the adverse changes induced by burn injury, including ER stress, lipotoxicity, and WAT browning, in both adipose tissue depots. Key messages Burn injury adversely affects adipose tissue metabolism via distinct changes in both visceral and subcutaneous adipose depots. Propranolol, a non-selective β-adrenergic blocker, attenuates many of the adverse adipose tissue changes mediated by burn injury.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>39145814</pmid><doi>10.1007/s00109-024-02478-w</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0003-0870-1664</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0946-2716
ispartof Journal of molecular medicine (Berlin, Germany), 2024-10, Vol.102 (10), p.1245-1254
issn 0946-2716
1432-1440
1432-1440
language eng
recordid cdi_proquest_miscellaneous_3093175795
source MEDLINE; SpringerNature Journals
subjects Adipose tissue
Adipose Tissue - drug effects
Adipose Tissue - metabolism
Adipose Tissue, White - drug effects
Adipose Tissue, White - metabolism
Adrenergic beta-Antagonists - pharmacology
Adrenergic beta-Antagonists - therapeutic use
Adrenergic receptors
Animal models
Animals
Biomedical and Life Sciences
Biomedicine
Body fat
Burn patients
Burns
Burns - drug therapy
Burns - metabolism
Catecholamines
Disease Models, Animal
Endoplasmic reticulum
Endoplasmic Reticulum Stress - drug effects
Energy expenditure
Energy Metabolism - drug effects
Human Genetics
Internal Medicine
Lipolysis
Lipolysis - drug effects
Male
Mice
Mice, Inbred C57BL
Molecular Medicine
Original Article
Pediatrics
Propranolol
Propranolol - pharmacology
Propranolol - therapeutic use
Thermal injury
title β-Adrenergic blockade attenuates adverse adipose tissue responses after burn
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T00%3A11%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=%CE%B2-Adrenergic%20blockade%20attenuates%20adverse%20adipose%20tissue%20responses%20after%20burn&rft.jtitle=Journal%20of%20molecular%20medicine%20(Berlin,%20Germany)&rft.au=Bieerkehazhi,%20Shayahati&rft.date=2024-10-01&rft.volume=102&rft.issue=10&rft.spage=1245&rft.epage=1254&rft.pages=1245-1254&rft.issn=0946-2716&rft.eissn=1432-1440&rft_id=info:doi/10.1007/s00109-024-02478-w&rft_dat=%3Cproquest_cross%3E3093175795%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3107521823&rft_id=info:pmid/39145814&rfr_iscdi=true